Form 4: Longeveron CFO Boosts Stake with Stock & Warrant Buy

Sentiment:

Insider Transaction Report 13 August 2025 6:00 PM

Longeveron Inc.'s Chief Financial Officer, Lisa Locklear, increased her beneficial ownership by purchasing 11,766 shares of Class A Common Stock and 29,415 warrants.

Capital raiseThe transaction involves the purchase of units, each comprising one share of Class A Common Stock and two and a half Class A Common Warrants, at a combined price of $0.85 per unit.This structure suggests a recent capital raise or private placement by Longeveron Inc., where these units were offered.

Better than expectedThe Chief Financial Officer's purchase of company stock and warrants indicates strong confidence in Longeveron Inc.'s future performance and valuation.This insider buying aligns management's interests with those of shareholders, which is typically viewed favorably by investors.

Summary

Lisa Locklear, Longeveron Inc.'s Chief Financial Officer, acquired 11,766 shares of Class A Common Stock and 29,415 Class A Common Warrants.
The transaction occurred on August 11, 2025.
The combined purchase price for each unit, consisting of one share of Class A Common Stock and two and a half Class A Common Warrants, was $0.85.
Following the transaction, Ms. Locklear directly owns 250,964 shares of Class A Common Stock and 29,415 Class A Common Warrants.
The warrants are exercisable immediately and expire on August 11, 2027, with an exercise price of $0.85 per share.

Sentiment

Score: 8

Explanation: The purchase of a significant number of shares and warrants by the Chief Financial Officer indicates strong insider confidence in the company's prospects and valuation, which is a highly positive signal for investors.

Positives

Longeveron Inc.'s Chief Financial Officer, Lisa Locklear, increased her direct beneficial ownership in the company, signaling confidence in future prospects.
The acquisition of 11,766 shares of Class A Common Stock and 29,415 warrants demonstrates management's commitment and alignment with shareholder interests.

Future Outlook

Industry Context

Longeveron operates in the biotechnology sector, a capital-intensive industry where management confidence, as demonstrated by insider buying, can be a crucial signal regarding the company's pipeline progress, clinical trial outcomes, or future strategic milestones.

Related Party Transactions

The Chief Financial Officer, Lisa Locklear, purchased securities directly from the issuer, which constitutes a related party transaction.

Stakeholder Impact

Shareholders: Positive signal due to insider confidence, potentially increasing investor trust and demand for the stock.
Management/Employees: Reinforces alignment of interests between management and shareholders.

Key Dates

Date	Description
08/11/2025	Transaction date for the purchase of Class A Common Stock and Warrants.
08/11/2025	Date warrants became exercisable.
08/11/2027	Warrant expiration date.
08/13/2025	Date the Form 4 was signed by the reporting person's attorney-in-fact.

Recommendation

buy

The Chief Financial Officer's direct purchase of company stock and warrants at a specified price signals strong confidence in Longeveron Inc.'s future value and strategic direction. This insider buying aligns management's interests with shareholders and is typically viewed as a positive indicator, suggesting potential upside for the stock.

Keywords

Longeveron, LGVN, insider trading, Form 4, beneficial ownership, stock purchase, warrants, CFO, Lisa Locklear, biotechnology, healthcare

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.